Home Topics Efficacy

Efficacy

A coronavirus vaccine developed by Britain’s University of Oxford and the pharmaceutical firm AstraZeneca has shown successful results in early trials. If it is approved by regulators, the vaccine appears suitable for a fast rollout around the globe

Coronavirus vaccine breakthrough raises hopes of rapid global rollout

A coronavirus vaccine developed by Britain’s University of Oxford and the pharmaceutical firm AstraZeneca has shown successful results in early trials. If it is approved by regulators, the vaccine appears suitable for a fast rollout around the globe.
Director General of the World Health Organization (WHO) Tedros Adhanom Ghebreyesus attends a news conference on the situation of the coronavirus (COVID-2019), in Geneva, Switzerland, February 28, 2020. REUTERS-Denis Balibouse-File Photo

Coronavirus cases surge as threat from antimicrobial resistance grows – WHO chief

More cases of COVID-19 have been reported in the past four weeks than in the first six months of the pandemic, the UN health agency chief told journalists on Friday as he launched a new report on the threat posed by antimicrobial resistance.

Drug targets unexpected weakness in advanced prostate cancer

The compound thymoquinone selectively kills prostate cancer cells at advanced stages, according to a new study published in Oncogene. Led by researchers at Kanazawa University, the study reports that these cells with a deletion of the SUCLA2 gene can be therapeutically targeted.
Pfizer and BioNTech are submitting an emergency authorisation request in the US which could allow its coronavirus vaccine to be used to treat high-risk populations in the country by mid-December.

Pfizer is first to apply for U.S. emergency use for coronavirus vaccine

Pfizer Inc said it would apply to U.S. health regulators on Friday for emergency use authorisation (EUA) of its COVID-19 vaccine, the first such application in a major step toward providing protection against the new coronavirus.
Japan has said it will approve the antiviral drug, Remdesivir, to treat coronavirus patients on Thursday.

WHO: Remdesivir not okay to treat coronavirus

The World Health Organisation (WHO) in a stunning announcement on Friday said Gilead’s drug remdesivir is no longer recommended for patients hospitalised with COVID-19, regardless of how ill they are.
The coronavirus vaccine being developed by Pfizer and BioNTech has been found to be 90% effective in preventing people from getting the virus.

Hope rises as Pfizer, BioNTech analysis shows coronavirus vaccine is 95% effective

A final analysis of the Phase 3 trial of Pfizer’s coronavirus vaccine shows it was 95% effective in preventing infections, even in older adults, and caused no serious safety concerns, the company said Wednesday.
AMCON chief Ahmed Kuru

Why AMCON must recover N5 trillion debt – chief

The Asset Management Corporation of Nigeria (AMCON) Managing Director/Chief Executive Officer, Ahmed Kuru, attested to the efficacy of the processes of receivership and winding up procedures as amended in the 2019 AMCON Act, which President Muhammadu Buhari signed into law last year.
The herbal medicine developed by Malagasy Institute of Applied Research and branded COVID-Organics, contains Artemisia - a plant on the Island used in the fight against malaria.

Niger receives coronavirus ‘remedy’ from Madagascar

Niger on Tuesday received a consignment of herbal tea that Madagascar’s president Andry Rajoelina has touted as a powerful remedy against the novel coronavirus.
Professor Moji Adeyeye, NAFDAC boss

NAFDAC: We have not approved any vaccines for clinical trial for coronavirus

The National Agency for Food and Drug Administration and Control, NAFDAC, said yesterday it has not approved any vaccines for clinical trial for coronavirus disease in the country.
Mojisola Christianah Adeyeye, Director General, NAFDAC

NAFDAC chief orders chloroquine manufacturing

Prof Mojisola Christianah Adeyeye, PhD, FAS, Director General of National Agency for Food and Drug Administration and Control (NAFDAC), has ordered manufacturing of Chloroquine, an old antimalarial, for emergency stock for possible clinical trial treatment of of Coronavirus (2019-nCoV).

NAFDAC seals 47 bakeries, water factories in Borno

National Agency for Food, Drug Administration and Control (NAFDAC) says it has sealed 22 bakeries and 25 “sachet water” factories during routine inspection in Maiduguri.

Minister: We have depreciated Boko Haram’s efficacy

The Federal Government on Monday reiterated its position that it has “largely depreciated the efficiency and efficacy of Boko Haram” insurgents.

Pharmacists council shuts down 321 pharmacies, drugs outlets in Bayelsa

The Pharmacists Council of Nigeria (PCN) at the weekend shut down over 321 pharmacies and patent medicine stores in Bayelsa State.

Recent Stories

BPE hands over Afam power plant to Transcorp

The Bureau of Public Enterprises (BPE) has handed over the Afam Power Plant in Oyigbo Local Government of Rivers State to Transcorp Power Consortium, which emerged the preferred bidder of the power asset, with a bid offer of N105 billion.
Food and Agriculture Organization (FAO)

FAO provides dry season farm inputs to 14,250 households in Borno

The United Nations Food and Agriculture Organisation (FAO) has provided dry season farm inputs to 14,250 households for the 2020-2021 dry season farming in troubled Borno State.
A mock-up of banned Muslim travellers' passport is placed outside the US Supreme Court, while it weighs the legality of President Donald Trump's travel ban targeting people from Muslim-majority countries in Washington, DC, US [Yuri Gripas-Reuters]

New Trump rule could require up to $15,000 bond for travel to US

The outgoing administration of US President Donald Trump issued a new temporary rule that could require tourist and business travellers from two dozen countries – most in Africa – to pay a bond of as much as $15,000 to visit the United States.
YINKA ODUMAKIN

Afenifere calls for implementation of 2014 Confab report

Rising from its monthly meeting held at the country home of its national leader, Pa Reuben Fasoranti in Akure, the Ondo state capital, the Group opposed the proposed rail line and an N30bn highway to connect the Niger Republic with Nigeria.
The House of Representatives Tuesday rebuffed a raise in prices of StarTimes satellite TV bouquet.

StarTimes GO partners tech brands on Black Friday sales

StarTimes GO, an e-shopping channel on pay-TV platform StarTimes, has partnered top retail and tech brands on Black Friday Sales on November 27.